1 Apr 2024Open access1cites
Aplasia Cutis Congenita Associated with a Fetus Papyraceus: A Case ReportPublisher siteIndian Journal of Paediatric Dermatology, Skin and Cellular Biology Research
Active, last published 2026
In cancer and skin lesions
Sarah
Saoud
Scholar“Research focused on Cancer and Skin Lesions and adjacent fields.”
Mohamed I University
Morocco
Claim Your ProfileMorocco1
H-index
3
Citations
Sarah has not officially claimed their profile. If you are Sarah, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
arah Saoud is a researcher working on Cancer and Skin Lesions. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sarah's work has been cited 3 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cancer and Skin Lesions×3Breast Lesions and Carcinomas×2
04 · Where I am
Affiliations
Affiliation on published researchMohamed I University, MoroccoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
3 works18 Jan 2024Open access2cites
Pseudoangiomatous stromal hyperplasia: a rare cause of gynecomastia in menPublisher siteCase Reports in Plastic Surgery and Hand Surgery, Cancer and Skin Lesions
27 Dec 2023Open access
Botryomycoma of the upper eyelid conjunctivaPublisher siteJFO Open Ophthalmology, Cancer and Skin Lesions
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sarah?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you